So far, anti-AD drugs include cholinesterase inhibitors, NMDA receptor antagonists, β-site amyloid precursor protein cutting enzyme 1(BACE1) inhibitors, and some protein kinase inhibitors, which can only delay the progression of the disease and cannot cure AD. This evidence concerns the gene BACE1 and Alzheimer disease.